共 85 条
[1]
Estey E., Dohner H., Acute myeloid leukaemia, Lancet, 368, pp. 1894-1907, (2006)
[2]
Reinhardt D., Antoniou E., Waack K., Pediatric acute myeloid leukemia—past, present, and future, J. Clin. Med., 11, (2022)
[3]
Yi M., Li A., Zhou L., Chu Q., Song Y., Wu K., Wu K., The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: Estimates based on the global burden of disease study 2017, J. Hematol. Oncol., 13, (2020)
[4]
Papaemmanuil E., Gerstung M., Bullinger L., Gaidzik V.I., Paschka P., Roberts N.D., Potter N.E., Heuser M., Thol F., Bolli N., Gundem G., Van Loo P., Martincorena I., Ganly P., Mudie L., McLaren S., O'Meara S., Raine K., Jones D.R., Teague J.W., Butler A.P., Greaves M.F., Ganser A., Dohner K., Schlenk R.F., Dohner H., Campbell P.J., Genomic classification and prognosis in acute myeloid leukemia, N. Engl. J. Med., 374, pp. 2209-2221, (2016)
[5]
Mrozek K., Heerema N.A., Bloomfield C.D., Cytogenetics in acute leukemia, Blood Rev., 18, pp. 115-136, (2004)
[6]
Estey E., Grimwade D., Amadori S., Appelbaum F.R., Dombret H., Ebert B.L., Fenaux P., Larson R.A., Levine R.L., Lo-Coco F., Naoe T., Niederwieser D., Ossenkoppele G.J., Sanz M., Sierra J., Tallman M.S., Tien H.-F., Wei A.H., Bloomfield C.D., Diagnosis and Management of AML in Adults: 2017 ELN Recommendations from an International Expert Panel, (2017)
[7]
Wang R., Xu Y., Wang B., Wang H., Wang M., Jing Y., Gao X., Yu L., Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study, Ann. Hematol., 103, pp. 61-71, (2024)
[8]
Wilson E.R., Helton N.M., Heath S.E., Fulton R.S., Payton J.E., Welch J.S., Walter M.J., Westervelt P., DiPersio J.F., Link D.C., Miller C.A., Ley T.J., Spencer D.H., Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells, Leukemia, 36, pp. 935-945, (2022)
[9]
Giacopelli B., Wang M., Cleary A., Wu Y.Z., Schultz A.R., Schmutz M., Blachly J.S., Eisfeld A.K., Mundy-Bosse B., Vosberg S., Greif P.A., Claus R., Bullinger L., Garzon R., Coombes K.R., Bloomfield C.D., Druker B.J., Tyner J.W., Byrd J.C., Oakes C.C., DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia, Genome Res., 31, pp. 747-761, (2021)
[10]
Handschuh L., Kazmierczak M., Milewski M.C., Goralski M., Luczak M., Wojtaszewska M., Uszczynska-Ratajczak B., Lewandowski K., Komarnicki M., Figlerowicz M., Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR, Int. J. Oncol., 52, pp. 656-678, (2018)